Early View of the Effectiveness of New Direct-Acting Antiviral (DAA) Regimens in Patients with Hepatitis C Virus (HCV)
Crossref DOI link: https://doi.org/10.1007/s12325-015-0258-5
Published Online: 2015-11-04
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Walker, David R.
Pedrosa, Marcos C.
Manthena, Shivaji R.
Patel, Nikil
Marx, Steven E.
Funding for this research was provided by:
AbbVie
Text and Data Mining valid from 2015-11-01
Version of Record valid from 2015-11-04
Article History
Received: 29 September 2015
First Online: 4 November 2015